As the use of generative artificial intelligence becomes ubiquitous, it is critical for companies to learn to recognize and avoid common traps associated with AI. The hazards range from u...
In this issue, we discuss recent enforcement actions involving investment advisers that allegedly made false and misleading statements about their use of artificial intelligence.
On March 13, the European Parliament passed a draft of the Artificial Intelligence Act. The AI Act includes requirements for U.S. businesses using or developing AI systems or general-purp...
Davis Polk partners David Bauer and Matt Bacal, counsel Samantha Lefland and law clerk Ted Talas authored “Artificial intelligence in drug development” in the Legal 500: Life Sciences...
Webinar
1.0 CA - General; NY - Professional Practice / Practice Management
Davis Polk is hosting a series of webinars focused on legal considerations for life sciences and healthcare companies. In this installment, senior lawyers discuss considerations and strat...
On February 12, 2024, the United States Patent and Trademark Office issued inventorship guidance for AI-assisted inventions. The guidance follows caselaw establishing that an AI system c...
Davis Polk partner David Lisson and associate Serge Voronov authored “What’s ahead when AI and intellectual property converge” in the Daily Journal. In the article, they discuss int...
Generative artificial intelligence (generative AI) tools pose new risks to a company’s trade secrets. This client update describes three steps that companies should consider to protect ...
Davis Polk partner and IP, Tech & Commercial Transactions head Frank Azzopardi, partners Matt Bacal and Pri Shah, and associate Josh Shirley co-authored “Important Generative AI Conside...
The recent rise of consumer and market interest in generative artificial intelligence (GAI) tools has spurred growing interest in GAI assets from strategic acquirers and private equity in...